Search PDMR transactions

Notifier
Name of person with notification obligation
Stefan Nilsson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Stefan Nilsson
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Lipigon Pharmaceuticals AB
Issuer´s LEI code
549300XPO40YR12SLY87
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Lipigon Pharmaceuticals AB SE0015382072 Acquisition 300,852 Quantity 0.336688 SEK 19/04/2024 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Lipigon Pharmaceuticals AB SE0015382072 Acquisition 19/04/2024 FIRST NORTH SWEDEN 300,852 (Quantity) 0.336688 SEK
Total: 300,852
<< Back